11-6319380-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_145040.3(CAVIN3):c.569G>A(p.Arg190Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000969 in 1,600,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145040.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAVIN3 | NM_145040.3 | c.569G>A | p.Arg190Gln | missense_variant | 2/2 | ENST00000303927.4 | NP_659477.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAVIN3 | ENST00000303927.4 | c.569G>A | p.Arg190Gln | missense_variant | 2/2 | 1 | NM_145040.3 | ENSP00000307292.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152212Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000112 AC: 26AN: 232484Hom.: 0 AF XY: 0.0000866 AC XY: 11AN XY: 126954
GnomAD4 exome AF: 0.0000994 AC: 144AN: 1448032Hom.: 0 Cov.: 67 AF XY: 0.000103 AC XY: 74AN XY: 719896
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152212Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.569G>A (p.R190Q) alteration is located in exon 2 (coding exon 2) of the PRKCDBP gene. This alteration results from a G to A substitution at nucleotide position 569, causing the arginine (R) at amino acid position 190 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at